Pancreatic cancer BRCA mutation and personalized treatment.

Breast Cancer Research from BioPortfolio
Pancreatic cancer BRCA mutation and personalized treatment.
The highly heterozygous nature of pancreatic cancer is partially responsible for its therapeutic ineffectiveness and resistance. Therefore the ability to identify subgroups of pancreatic cancer with unique biological characteristics and treatment response ...
Clinical Impact of ChemotherapyRelated Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System.
Stage IV breast cancer also known as metastatic breast cancer mBC is not a curable condition. However treatment can prolong life delay the progression of the cancer or improve quality of life. Currently patients with mBC are often treated with chemotherapy...
Latest Breast Cancer News from BioPortfolio
Lowcountry Affiliate of Susan G. Komen for the Cure Presents Swing for the Cure
A golf and tennis fundraising event supporting the fight against breast cancer.Charleston SC PRWEB September 25 2015 The Lowcountry Affiliate of Susan G. Komen announces Swing for the Cure a weekend fundraising event on Oct. 23 featuring golf and tennis t...

Comments

Post a Comment

Popular posts from this blog

2016 Estonia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical StainsTest Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers Prices from USD $4850

Image
ICYMI: bioportfolio.co.uk This new report from VPG Market Research provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerou
Read more

2016 Slovenia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical StainsTest Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers Prices from USD $4850

Image
bioportfolio.co.uk This new report from VPG Market Research provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; analyzes potential applications of innovative technologies; forecasts volume and sales for major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous oppor
Read more